| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $37.45B | $36.72B | $45.71B | $45.58B | $43.81B |
| Cost of Revenue | $24.93B | $24.46B | $30.85B | $30.57B | $30.09B |
| Gross Profit | $12.52B | $12.26B | $14.86B | $15.01B | $13.72B |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $5.45B | $5.77B | $6.09B | $5.71B | $5.35B |
| Operating Income | -$411.00M | $3.67B | $14.30B | $5.66B | $5.10B |
| Interest Expense | $1.93B | $2.63B | $1.73B | $1.96B | $1.03B |
| Tax Expense | $2.25B | $50.00M | $481.00M | $1.33B | $3.86B |
| Net Income | -$3.75B | $1.50B | $12.34B | $2.62B | $536.00M |
| EPS (basic) | -0.1594 | 0.0421 | 0.4277 | 0.0720 | 0.3800 |
| EPS (diluted) | -0.1594 | 0.0420 | 0.4262 | 0.0717 | 0.3800 |
| Shares (diluted) | $26.15B | $27.15B | $27.77B | $29.11B | $29.68B |